SEC Form D private-offering filing

Nocion Therapeutics, Inc.

A new SEC Form D private-offering notice from Watertown, MA, a $22,999,999 filer-stated offering target in Biotech. The source filing is one click away.

Nocion Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biopharmaceutical company developing taplucainium, an inhaled treatment for chronic cough, based on charged sodium channel blocker technology licensed from Harvard and Boston Children's Hospital.

Filed 2026-03-13Filed to raise $22,999,999First money in 2025-12-15Raised so far $22,999,999HQ (as filed) Watertown, MASector Biotech Stage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified nociontx.com↗Named in the filing 10 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.